T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
TAL Education Group
TAL
$6.58B
| $191M | 0.03% |
5,017,694
+3,452,556
| +221% | +$125M |
|
477
Equinix
EQIX
$105B
| $191M | 0.03% |
377,913
+13,471
| +4% | +$6.46M |
|
478
Tenaris
TS
$26.8B
| $191M | 0.03% |
7,241,802
+2,860,516
| +65% | +$76.5M |
|
|
CELG
479
DELISTED
Celgene Corp
CELG
| $189M | 0.03% |
2,043,873
-1,977,466
| -49% | -$188M |
|
480
Lattice Semiconductor
LSCC
$18.4B
| $189M | 0.03% |
12,942,516
-2,822,347
| -18% | -$37.6M |
|
481
Cognex
CGNX
$10.2B
| $189M | 0.03% |
3,934,543
-2,433,340
| -38% | -$117M |
|
482
Simply Good Foods
SMPL
$968M
| $187M | 0.03% |
7,776,722
+1,167
| +0% | +$26.5K |
|
|
NBIS
483
Nebius Group N.V.
NBIS
$65.8B
| $187M | 0.03% |
4,913,256
-134,767
| -3% | -$5M |
|
|
PR
484
Permian Resources
PR
$18B
| $186M | 0.03% |
24,493,385
-8,245,190
| -25% | -$73.3M |
|
485
Halliburton
HAL
$27.7B
| $184M | 0.03% |
8,108,725
+2,443,038
| +43% | +$63.4M |
|
486
Norfolk Southern
NSC
$75.3B
| $182M | 0.03% |
913,984
+31,581
| +4% | +$6.26M |
|
487
Colgate-Palmolive
CL
$73.6B
| $182M | 0.03% |
2,536,065
+11,319
| +0.4% | +$804K |
|
|
BLUE
488
DELISTED
bluebird bio
BLUE
| $181M | 0.03% |
109,683
-8,835
| -7% | -$15.3M |
|
489
Insmed
INSM
$28.9B
| $181M | 0.03% |
7,057,967
-827,528
| -10% | -$23.1M |
|
|
JOYY
490
JOYY Inc
JOYY
$3.74B
| $180M | 0.03% |
2,585,184
-255,160
| -9% | -$19.5M |
|
491
Carnival Corporation Ltd
CCL
$37.9B
| $180M | 0.03% |
3,868,390
+317,499
| +9% | +$16.6M |
|
492
First Industrial Realty Trust
FR
$8.4B
| $179M | 0.03% |
4,878,793
+86,199
| +2% | +$3.06M |
|
493
Banco Bradesco
BBD
$34.9B
| $179M | 0.03% |
24,281,305
-2,137,501
| -8% | -$14.6M |
|
494
Selective Insurance
SIGI
$5.59B
| $179M | 0.03% |
2,391,878
-23,572
| -1% | -$1.68M |
|
495
Radian Group
RDN
$4.87B
| $178M | 0.03% |
7,779,020
-38,230
| -0.5% | -$872K |
|
496
Workiva
WK
$3.7B
| $177M | 0.02% |
3,039,123
-2,960
| -0.1% | -$159K |
|
|
MYOK
497
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $176M | 0.02% |
3,516,869
+132,654
| +4% | +$6.46M |
|
|
GTLS
498
DELISTED
Chart Industries
GTLS
| $175M | 0.02% |
2,282,574
-1,291,655
| -36% | -$106M |
|
499
PTC Therapeutics
PTCT
$6.06B
| $174M | 0.02% |
3,867,289
+342,747
| +10% | +$13.5M |
|
500
Brighthouse Financial
BHF
$3.44B
| $174M | 0.02% |
4,741,394
-1,220,061
| -20% | -$47.1M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.